[{"AccountsPayableCurrent_0_Q2_USD":19701000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":845000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-4090000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4016000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-1105000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-279000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-275000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-215000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-830000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-64000.0,"OtherAssetsNoncurrent_0_Q2_USD":344000.0,"OtherAssetsCurrent_0_Q2_USD":12596000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":16404000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":122362000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":131658000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":16776000.0,"OperatingIncomeLoss_2_Q2_USD":-219597000.0,"OperatingIncomeLoss_1_Q2_USD":-110205000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NonoperatingIncomeExpense_2_Q2_USD":-28440000.0,"NonoperatingIncomeExpense_1_Q2_USD":-14957000.0,"NetIncomeLoss_2_Q2_USD":-248486000.0,"NetIncomeLoss_1_Q2_USD":-125519000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-159986000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":83410000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":30023000.0,"LiabilitiesFairValueAdjustment_2_Q2_USD":-4312000.0,"LiabilitiesFairValueAdjustment_1_Q2_USD":-2713000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":2257000.0,"LiabilitiesCurrent_0_Q2_USD":131023000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":527887000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":182698000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":182038000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":12553000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_2_Q2_shares":3682000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_1_Q2_shares":1483000.0,"StockholdersEquity_0_Q2_USD":904975000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":10.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":9.78,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_Q2_shares":278000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1_Q2_shares":157000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1057000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":51977000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":28330000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2557644000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":5795000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":196917000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":101313000.0,"RepaymentsOfSeniorDebt_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":58599000.0,"ProfitLoss_2_Q2_USD":-248486000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":5035000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":612419000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":28523000.0,"ProceedsFromDerivativeInstrumentFinancingActivities_2_Q2_USD":1500000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":6157000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":182698000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1371351000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":9753000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":7667000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":39300000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":20500000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-249591000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-125798000.0,"CommonStockValue_0_Q2_USD":18000.0,"CommonStockSharesOutstanding_0_Q2_shares":183773000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-46610000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":152345000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":152345000.0,"Cash_0_Q2_USD":14056000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":57397000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":847720000.0,"AssetsCurrent_0_Q2_USD":1056148000.0,"Assets_0_Q2_USD":1371351000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":18870000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":18352000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":23714000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":47612000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":23714000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":3466001000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-3400000.0,"AccountsReceivableNetCurrent_0_Q2_USD":28871000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":13423000.0,"Liabilities_0_Q2_USD":466376000.0,"CostsAndExpenses_1_Q2_USD":138535000.0,"DepreciationAndAmortization_2_Q2_USD":7090000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1996000.0,"InventoryNet_0_Q2_USD":14616000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2867000.0,"InterestPaidNet_2_Q2_USD":0.0,"InterestExpense_2_Q2_USD":0.0,"InterestExpense_1_Q2_USD":0.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-11585000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":-3496000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-676000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":14133000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-605000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-10018000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2101000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":449000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":357000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-248037000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-125162000.0,"Goodwill_0_Q2_USD":76501000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":61234000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":29555000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":28665000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-57000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.69,"EarningsPerShareDiluted_2_Q2_USD":-1.37,"EarningsPerShareBasic_2_Q2_USD":-1.37,"EarningsPerShareBasic_1_Q2_USD":-0.69,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":11607000.0,"CostsAndExpenses_2_Q2_USD":271574000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":182038000.0,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]